Surgical practice patterns following NCCTG N0338 Phase II trial of docetaxel and darboplatin administered every two weeks as induction therapy for stage II and stage III breast cancer. Apsey, H. , Roy, V. , Pockaj, B. , Northfelt, D. , Sticca, R. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Breast - NCCTG-N0338
Effect of Docetaxel and Carboplatin on VEGF, PGE2, and Immune cells in Patients With Stage II or III Breast Cancer Pockaj, B. , Tinder, T. , Klosterman, C. , Allred, J. , Roy, V. ... - SABCS - Cancer Res. - 2009 Abstract - Secondary - Primary - Breast - N0338
Circulating tumor cells in North Central Cancer Treatment Group breast clinical trials Reinholz, M. , Kitzmann, K. , Tenner, K. , Hillman, D. , Hobday, T. ... - ISMRC - 7th International Symposium on Minimal Residual Cancer - 2009 Abstract - Secondary-not-in-original - Comprehensive - Breast - N0234 , N0336 , N0338 , N0436 , N0437
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group (NCCTG) trials, N0234/336/436/437 Reinholz, Monica M. , Kitzmann, Kathleen A. , Tenner, Kathleen ... - - Clin. Cancer Res. - 2011 Manuscript - Secondary-not-in-original - Primary - Breast - N0336 , N0234 , N0338 , N0436 , N0437
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531) Roy, V. , LaPlant, B. R. , Gross, G. G. , Bane, C. L. ... - - Ann Oncol - 2009 Manuscript - Primary - Primary - Breast - NCCTG-0531
NCCTG phase II trial N0531of weekly nab-paclitaxel (nab-p) in combination with gemcitabine (gem) in patients with metastatic breast cancer (MBC) Roy, V. , Laplant, B. , Gross, G. , Palmieri, F. ... - - J. Clin. Oncol. - 2007 Abstract - Primary - Primary - Breast - N0531
N0338 phase II trial of docetaxel and carboplatin administered every two weeks as induction therapy for stage II or III breast cancer Roy, V. , Pockaj, B. , Northfelt, D. , Allred, J. , Liu, H. ... - - J. Clin. Oncol. - 2008 Abstract - Primary - Primary - Breast - N0338
A Phase II trial of docetaxel and carboplatin administered every two weeks as preoperative therapy for stage II or III breast cancer: NCCTG Study N0338 Roy, Vivek , Pockaj, Barbara A. , Allred, Jacob B. , Apsey, Heidi ... - - Am. J. Clin. Oncol. - 2013 Manuscript - Primary - Primary - Breast - N0338
Benefit of adjuvant trastuzumab in breast cancer patients with focal HER2 amplified clones: Data from N9831 Intergroup Adjuvant Trial Sukov, W. R. , Miller, D. V. , Dueck, A. C. , Tenner, K. S. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary - Primary - Breast - N9831
